Status:
COMPLETED
Pilot Study of a New Nicotine Replacement Therapy
Lead Sponsor:
McNeil AB
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Pilot study of a new nicotine replacement therapy for smoking cessation.
Detailed Description
This will be a pilot study of a new nicotine replacement therapy with two different directions for use in smoking cessation.
Eligibility Criteria
Inclusion
- 18 years or older male and female cigarette smokers motivated and willing to stop smoking
- female participants of child-bearing potential should use a medically acceptable means of birth control
- evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study and consents to participate
Exclusion
- unstable angina pectoris or myocardial infarction during the previous 3 months
- pregnancy, lactation or intended pregnancy (non-pregnancy will be verified by urine pregnancy test for female participants of child-bearing potential)
- participation in other clinical trials within the previous three months and during study participation
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
258 Patients enrolled
Trial Details
Trial ID
NCT00764439
Start Date
October 1 2008
End Date
December 1 2008
Last Update
July 10 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Primary Care and General Practice, University of Birmingham
Birmingham, United Kingdom, B15 2TT
2
Tobacco Dependence Research Centre at Barts and The London Queen Mary's School of Medicine and Dentistry
London, United Kingdom, E1 2AD